In the article “Community-associated methicillin-resistant Staphylococcus aureus infection,” which appeared in the July issue of Canadian Family Physician,1 an error was inadvertently introduced in Table 2. The correct version of the table appears below.
Table 2.
SSTI | TREATMENT |
---|---|
Simple cutaneous abscess (in a low-risk patient not involving face, hands, or genitalia) | Incision and drainage alone; obtain culture |
Purulent cellulitis (without abscess): treat for CA-MRSA if risk factors present | Tetracycline, trimethoprim-sulfamethoxazole, or clindamycin |
Nonpurulent cellulitis (no exudate): treat for β-hemolytic streptococcus | β-Lactam antibiotic (cloxacillin or first-generation cephalosporin) |
CA-MRSA—community-associated methicillin-resistant Staphylococcus aureus, SSTI—skin and soft tissue infection.
A detailed management algorithm is available within the Infectious Diseases Society of America guidelines 2014 update on SSTIs.74 All recommendations are level II evidence, adapted from the Infectious Diseases Society of America 2011 guidelines.65
Canadian Family Physician apologizes for this error and any confusion it might have caused.
Reference
- 1.Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L. Community-associated methicillin-resistant Staphylococcus aureus infection. Literature review and clinical update. Can Fam Physician. 2017;63:512–20. [PMC free article] [PubMed] [Google Scholar]